查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561539

2024-2032 年按應用、服務、最終用途和地區分類的計算生物學市場報告

Computational Biology Market Report by Application, Services, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2023年全球計算生物學市場規模達58IMARC Group美元。

計算生物學，也稱為生物資訊學，是一門跨學科的科學分支，它利用數學、統計學和電腦科學來理解和建模生命的結構和過程。它涉及生物學的各個方面，如遺傳學、進化論、細胞生物學和生物化學。該過程使用包括演算法在內的計算技術來表示和模擬生物系統並解釋大規模的實驗資料。計算生物學還透過根據氨基酸序列、核苷酸和大分子結構創建生物資訊資料庫來幫助了解疾病和細胞功能的治療。如今，計算生物學已成為生物研究計畫的重要組成部分，包括人類基因組計畫、蛋白質資料和基因組資料庫。

計算生物學市場趨勢：

全球計算生物學市場主要受到藥物基因組學領域臨床研究數量不斷增加的推動。這有助於增加對患者群體的多樣化生物組成、生物途徑以及支撐它們的基因組的了解。因此，對計算生物學解決方案的需求很高，因為它們有助於減少藥物發現和各種其他科學實驗所需的總時間。該過程還有助於模擬高級藥物相互作用的工具的可視化。除此之外，表觀基因體學、蛋白質體學和宏基因體學中計算生物學對蛋白質結構和交互作用的需求不斷成長，也推動了市場的成長。此外，藥物開發和疾病建模方面的各種技術進步，以及私人和政府組織對研發（R＆D）活動的​​投資增加，預計也將在不久的將來為市場提供積極的推動力。

本報告回答的關鍵問題

  • 2023 年全球計算生物學市場規模有多大？ 2024-2032年全球計算生物學市場的預期成長率是多少？
  • 推動全球計算生物學市場的關鍵因素是什麼？
  • COVID-19 對全球計算生物學市場有何影響？
  • 基於應用的全球計算生物學市場的細分是什麼？
  • 基於服務的全球計算生物學市場的細分是什麼？
  • 根據最終用途，全球計算生物學市場的細分是什麼？
  • 全球計算生物學市場的關鍵區域有哪些？
  • 誰是全球計算生物學市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球計算生物學市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按應用

  • 細胞和生物模擬
    • 市場趨勢
    • 關鍵環節
      • 計算基因組學
      • 計算蛋白質體學
      • 藥物基因組學
      • 其他
    • 市場預測
  • 藥物發現與疾病建模
    • 市場趨勢
    • 關鍵環節
      • 目標識別
      • 目標驗證
      • 潛在客戶發現
      • 潛在客戶最佳化
    • 市場預測
  • 臨床前藥物開發
    • 市場趨勢
    • 關鍵環節
      • 藥物動力學
      • 藥效學
    • 市場預測
  • 臨床試驗
    • 市場趨勢
    • 關鍵環節
      • 第一階段
      • 第二階段
      • 第三階段
    • 市場預測
  • 人體模擬軟體
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按服務

  • 內部
    • 市場趨勢
    • 市場預測
  • 合約
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：最終用途別

  • 學者
    • 市場趨勢
    • 市場預測
  • 醫藥行業
    • 市場趨勢
    • 市場預測
  • 商業的
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Certara
    • Chemical Computing Group ULC
    • Compugen Ltd
    • Dassault Systemes
    • Genedata AG
    • Insilico Biotechnology AG
    • Instem plc
    • Nimbus Therapeutics LLC
    • Schrodinger Inc.
    • Simulations Plus Inc.
Product Code: SR112024A4495

The global computational biology market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.3 Billion by 2032, exhibiting a growth rate (CAGR) of 18.8% during 2024-2032.

Computational biology, also known as bioinformatics, is the interdisciplinary branch of science that uses math, statistics and computer science for understanding and modeling the structures and processes of life. It involves various aspects of biology, such as genetics, evolution, cell biology, and biochemistry. The process uses computational techniques, including algorithms, to represent and simulate biological systems and interpret experimental data on a large scale. Computational biology also helps understand the treatment for diseases and cellular function by creating a database of biological information from amino-acid sequences, nucleotides, and macromolecular structures. Nowadays, computational biology has become an essential part of biological research projects, including the human genome project, protein data banks and genomic databases.

Computational Biology Market Trends:

The global computational biology market is primarily driven by the rising number of clinical studies in the field of pharmacogenomics. This has helped increase the understanding of the diverse biological makeup of the patient population, biological pathways, and the genomes underpinning them. As a result, there is a high demand for computational biology solutions, as they help reduce the overall time needed for drug discovery and various other scientific experiments. The process also aids the visualization of tools to simulate advanced drug-drug interactions. In addition to this, the growing demand for computational biology in epi-genomics, proteomics, and meta-genomics to undertint protein structures and interactions is also propelling the market growth. Furthermore, various technological advancements in drug development and disease modeling, along with increasing investments by private and government organizations in research and development (R&D) activities, are also anticipated to provide a positive thrust to the market in the near future.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global computational biology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application, services and end use.

Breakup by Application:

  • Cellular and Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others
  • Drug Discovery and Disease Modelling
    • Target Identification
    • Target Validation
    • Lead Discovery
    • Lead Optimization
  • Preclinical Drug Development
    • Pharmacokinetics
    • Pharmacodynamics
  • Clinical Trials
    • Phase I
    • Phase II
    • Phase III
  • Human Body Simulation Software

Breakup by Services:

  • In-house
  • Contract

Breakup by End Use:

  • Academics
  • Pharmaceutical Industry
  • Commercial

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systemes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrodinger Inc. and Simulations Plus Inc

Key Questions Answered in This Report

  • 1. What was the size of the global computational biology market in 2023?
  • 2. What is the expected growth rate of the global computational biology market during 2024-2032?
  • 3. What are the key factors driving the global computational biology market?
  • 4. What has been the impact of COVID-19 on the global computational biology market?
  • 5. What is the breakup of the global computational biology market based on the application?
  • 6. What is the breakup of the global computational biology market based on the services?
  • 7. What is the breakup of the global computational biology market based on the end use?
  • 8. What are the key regions in the global computational biology market?
  • 9. Who are the key players/companies in the global computational biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Computational Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Cellular and Biological Simulation
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Computational Genomics
      • 6.1.2.2 Computational Proteomics
      • 6.1.2.3 Pharmacogenomics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Drug Discovery and Disease Modelling
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Target Identification
      • 6.2.2.2 Target Validation
      • 6.2.2.3 Lead Discovery
      • 6.2.2.4 Lead Optimization
    • 6.2.3 Market Forecast
  • 6.3 Preclinical Drug Development
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Pharmacokinetics
      • 6.3.2.2 Pharmacodynamics
    • 6.3.3 Market Forecast
  • 6.4 Clinical Trials
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Phase I
      • 6.4.2.2 Phase II
      • 6.4.2.3 Phase III
    • 6.4.3 Market Forecast
  • 6.5 Human Body Simulation Software
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Services

  • 7.1 In-house
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Contract
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Academics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical Industry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Commercial
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Certara
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Chemical Computing Group ULC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Compugen Ltd
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Dassault Systemes
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Genedata AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Insilico Biotechnology AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Instem plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Nimbus Therapeutics LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Schrodinger Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Simulations Plus Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Computational Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Computational Biology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Computational Biology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Computational Biology Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Computational Biology Market: Breakup by Services (in %), 2023
  • Figure 6: Global: Computational Biology Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Computational Biology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Computational Biology (Cellular and Biological Simulation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Computational Biology (Cellular and Biological Simulation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Computational Biology (Drug Discovery and Disease Modelling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Computational Biology (Drug Discovery and Disease Modelling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Computational Biology (Preclinical Drug Development) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Computational Biology (Preclinical Drug Development) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Computational Biology (Clinical Trials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Computational Biology (Clinical Trials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Computational Biology (Human Body Simulation Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Computational Biology (Human Body Simulation Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Computational Biology (In-house) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Computational Biology (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Computational Biology (Contract) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Computational Biology (Contract) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Computational Biology (Academics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Computational Biology (Academics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Computational Biology (Pharmaceutical Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Computational Biology (Pharmaceutical Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Computational Biology (Commercial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Computational Biology (Commercial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Computational Biology Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Computational Biology Industry: SWOT Analysis
  • Figure 78: Global: Computational Biology Industry: Value Chain Analysis
  • Figure 79: Global: Computational Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Computational Biology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Computational Biology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Computational Biology Market Forecast: Breakup by Services (in Million US$), 2024-2032
  • Table 4: Global: Computational Biology Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Computational Biology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Computational Biology Market: Competitive Structure
  • Table 7: Global: Computational Biology Market: Key Players